Status:

COMPLETED

Effects of Enzymatic Digestion and Probiotic on Oleuropein Bioavailability

Lead Sponsor:

Société des Produits Nestlé (SPN)

Conditions:

Healthy Subjects

Eligibility:

All Genders

25-65 years

Phase:

NA

Brief Summary

This is a 3-arms randomized-controlled, parallel group, single center, double-blind study investigating the bioavailability of olive oil extract (OLE) in two different OLE formulations (enzymatically ...

Detailed Description

Male or female healthy adults between 25 and 65 years of age will be randomized into one of the 3 following groups to receive: 1. Capsule of OLE + 1 stick of maltodextrin 2. Capsule of OLE enzymatica...

Eligibility Criteria

Inclusion

  • Willing and able to sign written informed consent prior to trial entry
  • Male or female healthy adults between 25 and 65 years of age
  • Body Mass Index (BMI) within the range 18.5 - 29.9 (both inclusive)
  • In good health as determined by medical judgment and medical history

Exclusion

  • Any food allergy/intolerance
  • Subjects not willing and/or not able to comply with scheduled visits and the requirements of the study protocol
  • Taking or anticipated initiation of any lipid-modifying or blood-clotting medication e.g. statins, cholesterol lowering
  • Smokers
  • Alcohol intake higher than 2 servings per day (one serving is 0.4 dL of strong alcohol, 1 dL of wine, or 3 dL of beer) or drug abuse
  • Receiving or having received antibiotics in the past 4 weeks prior to the day of inclusion
  • Overly imbalanced or restrictive diet (e.g. hyperproteic, vegan, ketogenic, etc.)
  • Hormonal treatment for women linked to menopause (contraceptive treatment accepted)
  • Pregnancy or breastfeeding
  • Supplements or foods containing probiotics (yogurts allowed)
  • Currently participating or having participated in another clinical trial within 4 weeks prior to trial start

Key Trial Info

Start Date :

February 10 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 15 2021

Estimated Enrollment :

104 Patients enrolled

Trial Details

Trial ID

NCT04328571

Start Date

February 10 2020

End Date

September 15 2021

Last Update

October 1 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Universidad Católica San Antonio

Murcia, Spain, 30107